Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c1132
Identifier NCT05112263
Trial Title Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Tofacitinib|DRUG: Cyclosporine
Participant Information
Sponsor Post Graduate Institute of Medical Education and Research, Chandigarh
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2023-07-01
Primary Completion Date 2025-12-01
Completion Date 2026-06-01